ConductScience.org, home

Paper832019

Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.

Kanis JA and 1 other. Br Med J, 1977. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives. Papers, record 832019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/832019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.
PubMed
Journal
Br Med J
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
3.54
iCite
Revised in PubMed
2019-05-01
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kanis JAJ A
2Russell RGR G

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CalciumMajor topic
DihydrotachysterolMajor topic
HydroxycholecalciferolsMajor topic
HypercalcemiaMajor topic
Vitamin DMajor topic
Dihydroxycholecalciferols
Humans
Time Factors

Source PubMed

Download CSV of topics

References4

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
157505Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.Lancet1976https://conductscience.org/library/papers/57505PubMed
241344071,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.Lancet1974https://conductscience.org/library/papers/4134407PubMed
34131033Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.Lancet1974https://conductscience.org/library/papers/4131033PubMed
4170516Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.N Engl J Med1975https://conductscience.org/library/papers/170516PubMed

Download CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
33133833From Psychiatry to Neurology and Endocrinology: A Case of Hypoparathyroidism.Cureus2020https://conductscience.org/library/papers/33133833PubMed
32738041Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).J Clin Endocrinol Metab2020https://conductscience.org/library/papers/32738041PubMed
29694629Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism.Arch Endocrinol Metab2018https://conductscience.org/library/papers/29694629PubMed
29633734Current treatment of hypoparathyroidism: Theory versus reality waiting guidelines for children and adolescents.Acta Biomed2018https://conductscience.org/library/papers/29633734PubMed
28324108Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol.J Clin Endocrinol Metab2017https://conductscience.org/library/papers/28324108PubMed
26938200Management of Hypoparathyroidism: Present and Future.J Clin Endocrinol Metab2016https://conductscience.org/library/papers/26938200PubMed
26318020Reversible vascular calcifications associated with hypervitaminosis D.J Nephrol2016https://conductscience.org/library/papers/26318020PubMed
22090268Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.J Clin Endocrinol Metab2012https://conductscience.org/library/papers/22090268PubMed
21812031Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.J Bone Miner Res2011https://conductscience.org/library/papers/21812031PubMed
9536328Vitamin D and analogues in renal bone disease and implications for osteoporosis.Osteoporos Int1997https://conductscience.org/library/papers/9536328PubMed
9536320Treatment of osteoporosis with vitamin D.Osteoporos Int1997https://conductscience.org/library/papers/9536320PubMed
7429331Treatment of bone disease after jejunoileal bypass for obesity with oral 1 alpha-hydroxyvitamin D3.Gut1980https://conductscience.org/library/papers/7429331PubMed
7312738Hypercalcaemia in alphacalcidol therapy.Postgrad Med J1981https://conductscience.org/library/papers/7312738PubMed
7033299Osteomalacia and chronic renal failure.J Clin Pathol1981https://conductscience.org/library/papers/7033299PubMed
6489426Effect of bendrofluazide on calcium reabsorption in hypoparathyroidism.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6489426PubMed
6412828Renal handling of calcium in hypoparathyroidism.Br Med J (Clin Res Ed)1983https://conductscience.org/library/papers/6412828PubMed
6307498Studies on the mode of action of vitamin D XXXVII 1 alpha-hydroxyvitamin D3: a long-acting 1,25-dihydroxyvitamin D3 analog.Calcif Tissue Int1983https://conductscience.org/library/papers/6307498PubMed
62968681 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells.Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6296868PubMed
6262039Pharmacology and therapeutic use of vitamin D and its analogues.Drugs1981https://conductscience.org/library/papers/6262039PubMed
6246841Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.Arch Dis Child1980https://conductscience.org/library/papers/6246841PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/832019

GET https://conductscience.org/api/papers/v1/832019/cited_by?page=2